Cargando…
PI3K in stemness regulation: from development to cancer
The PI3K/AKT pathway is a key target in oncology where most efforts are focussed on phenotypes such as cell proliferation and survival. Comparatively, little attention has been paid to PI3K in stemness regulation, despite the emerging link between acquisition of stem cell-like features and therapeut...
Autor principal: | Madsen, Ralitsa R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054754/ https://www.ncbi.nlm.nih.gov/pubmed/32010943 http://dx.doi.org/10.1042/BST20190778 |
Ejemplares similares
-
PI3K signaling through a biochemical systems lens
por: Madsen, Ralitsa R., et al.
Publicado: (2023) -
Perspective: Potential Impact and Therapeutic Implications of Oncogenic PI3K Activation on Chromosomal Instability
por: Vanhaesebroeck, Bart, et al.
Publicado: (2019) -
Positive correlation between transcriptomic stemness and PI3K/AKT/mTOR signaling scores in breast cancer, and a counterintuitive relationship with PIK3CA genotype
por: Madsen, Ralitsa R., et al.
Publicado: (2021) -
Development and safety of PI3K inhibitors in cancer
por: Yu, Miaomiao, et al.
Publicado: (2023) -
Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases
por: Rodgers, Samuel J., et al.
Publicado: (2017)